515 filings
Page 2 of 26
424B3
pobx f442bv
14 Aug 20
Prospectus supplement
5:22pm
424B3
21yddjiyw
31 Jul 20
Prospectus supplement
12:00am
EFFECT
bdkc0l
29 Jul 20
Notice of effectiveness
12:15am
CORRESP
vu0frbs9pgz kc
24 Jul 20
Correspondence with SEC
12:00am
D/A
oi17c1nxo 9hy
23 Jul 20
Indefinite amount in debt / Debt convertible into equity., sold $5.61M, 18 investors
5:00pm
UPLOAD
s69bu57i01i62r2v
22 Jul 20
Letter from SEC
12:00am
8-K
z24m603wsrud47yq1bnb
9 Jul 20
Entry into a Material Definitive Agreement
4:16pm
8-K
mka06xez hdur5
23 Jun 20
Entry into a Material Definitive Agreement
5:00pm
8-K
gxcr4xopff ss
19 Jun 20
Entry into a Material Definitive Agreement
4:15pm
D
38s6t z48gpm3z7j
12 Jun 20
Indefinite amount in debt / Debt convertible into equity, sold $2.42M, 9 investors
4:46pm
SC 13G
nagakpk5gj2gote
10 Jun 20
GT Biopharma / BRISTOL INVESTMENT FUND ownership change
8:08am
4
lttij4sawd51
4 Jun 20
GT Biopharma / Tony Cataldo ownership change
5:15pm
8-K
9ibbn534
29 May 20
Regulation FD Disclosure
4:15pm
SC 13G/A
vept2d
18 May 20
GT Biopharma / BRISTOL INVESTMENT FUND ownership change
4:06pm
4
u0tnp657eqjisd5eo08
14 May 20
GT Biopharma / Steven W Weldon ownership change
1:40pm